Ally Bridge Group »

Ibio shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Ibio (IBIO) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Ibio

Tip: Access up to 7 years of quarterly data

All positions including Ibio held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ibio by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $683k 390k 1.75

More positions owned by Ally Bridge Group

Definium Therapeutics Com Shs Call Option (DFTX)
Abivax Sa Sponsored Ads Call Option (ABVX)
Minerva Neurosciences Com New (NERV)
Promis Neurosciences Com Shs (PMN)
First Tracks Biotherapeutics Ord Shs (TRAX)
Axsome Therapeutics (AXSM)
Assembly Biosciences Com New (ASMB)
Aadi Bioscience (WHWK)
Edgewise Therapeutics (EWTX)
Eliem Therapeutics (CLYM)
Kura Oncology (KURA)
Cytomx Therapeutics (CTMX)
Avalo Therapeutics Sponsored Ads (AVTX)
Palisade Bio (PALI)
Solid Biosciences (SLDB)

View all positions for Ally Bridge Group

Top funds holding Ibio

Affinity Asset Advisors
Cormorant Asset Management
Silverarc Capital Management
Vestal Point Capital
Vanguard Capital Management
Frazier Life Sciences Management
Ensign Peak Advisors
Woodline Partners
Millennium Management
Citadel Advisors
Balyasny Asset Management
Bank of America Corporation
Ikarian Capital
Sio Capital Management
Marshall Wace

View all funds holding Ibio